Transforming preclinical drug discovery to ensure clinical success in cancer treatment.
Our goal is to substantially reduce drug development costs by enabling the selection of effective candidates with minimal resistance induction.
+
Research & Preclinical study kits available
Research & Preclinical study kits available
+
Novel therapeutic approach validation
Novel therapeutic approach validation
+
Promising drug candidate identification
Promising drug candidate identification
Smarter drug discovery to promote efficiency and Reduce the development costs of cancer therapy
Building conditions for the development of efficient drugs against fibrosis and cancers
We use the current knowledge of the actual implication of fibrosis and excessive matrix synthesis in the failure of anti-cancer drug to design and develop novel products allowing the monitoring and evaluation of the fibrosis and resistance-inducing potentials of drug candidates in preclinical studies ensuring success in clinical trials.
